Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000935836-25-000324·Logos Global Management LP
Schedule 13D ownership disclosure
Olema Pharmaceuticals Inc
Common Stock · CUSIP: 68062P106
Event date: 2025-03-18
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Logos Global Management LPReported CIK 0001792126
Shares: 3,208,875.00 · Class: 4.7%
- Logos Global Management GP LLC
Shares: 3,208,875.00 · Class: 4.7%
- Arsani WilliamReported CIK 0001848372
Shares: 3,208,875.00 · Class: 4.7%
- Graham WalmsleyReported CIK 0001777517
Shares: 3,208,875.00 · Class: 4.7%
- Logos Opportunities GP LLC
Shares: 708,114.00 · Class: 1.0%
- Logos GP LLC
Shares: 2,508,114.00 · Class: 3.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000935836-25-000324
- Form type
- SCHEDULE 13D/A
- Filer
- Logos Global Management LP
- CIK
- CIK 1792126
- Filed
- May 13, 2025
- Reporting period
- Mar 18, 2025
- Description
- Schedule 13D beneficial ownership